LXRX Stock Analysis: Buy, Sell, or Hold?
LXRX - Lexicon Pharmaceuticals, Inc.
$1.16
-0.28 (-19.44%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 05, 2026
Smart Money Accumulation
LXRX is down 31.8% this week, but smart money is accumulating calls. Top strike: $2 2026-03-20 with 1,322 OI. Call ratio: 85% View Scanner →
Strength: 10.0/10
Get Alerted When LXRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
4 traders called LXRX this week
75% bullish • 1 bearish
75% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: LXRX is down 31.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: LXRX is down 31.8% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: LXRX is currently trading at $1.16, which is considered slightly low relative to its 30-day fair value range of $1.12 to $1.50.
Technical Outlook: Technically, LXRX is in a strong uptrend. Immediate support is located at $1.10, while resistance sits at $1.83. Short-term momentum is weak, with the stock down 19.4% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.92 (+151.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LXRX is in a strong uptrend. Immediate support is located at $1.10, while resistance sits at $1.83. Short-term momentum is weak, with the stock down 19.4% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.92 (+151.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$1.12 -
$1.50
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
Protect Your Profits
Holding LXRX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-19.4%)
- BULLISH: Trading 151.7% below Wall St target ($2.92)
- WARNING: Recommendation downgraded due to -31.8% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$1.12 -
$1.50
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.10
Resistance Level
$1.83
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-4.70
Wall Street Target
$2.92
(+151.7%)
Revenue Growth (YoY)
710.4%
Earnings Growth (YoY)
-63.4%
Profit Margin
-96.8%
Last updated: February 01, 2026 8:07 AM ET
Data refreshes hourly during market hours. Next update: 9:07 AM
Data refreshes hourly during market hours. Next update: 9:07 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LXRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 63 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$56 | 59 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$210 | 57 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 56 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$8 | 53 HOLD |
Advanced LXRX Option Strategies
Professional options setups generated by AI based on today's LXRX price and gamma walls.